AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ASELSAN ELEKTRONİK SANAYİ VE TİCARET A.Ş.

Quarterly Report Apr 29, 2025

5891_rns_2025-04-29_510c2ed3-b50b-4c11-9a56-80b9c42f786f.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

(Convenience Translation of Consolidated Financial Statements and Related Disclosures and Footnotes Originally Issued in Turkish)

ASELSAN ELEKTRONİK SANAYİ VE TİCARET ANONİM ŞİRKETİ AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF AND FOR THE THREE-MONTH PERIOD ENDED 31 MARCH 2025

29 April 2025

This report contains condensed consolidated interim financial information and related disclosures and footnotes comprising 45 pages.

1. ORGANIZATION AND OPERATIONS OF THE GROUP 8
2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS9
3. CASH AND CASH EQUIVALENTS 18
4. RELATED PARTY DISCLOSURES19
5. TRADE RECEIVABLES AND PAYABLES24
6. INVENTORIES 25
7. PREPAID EXPENSES AND DEFERRED INCOME26
8. PROPERTY, PLANT AND EQUIPMENT27
9. PROVISIONS, CONTINGENT ASSETS AND LIABILITIES28
10. TAX29
11. COMMITMENTS AND CONTINGENCIES 29
12. EMPLOYEE BENEFITS 32
13. SHARE CAPITAL, RESERVES AND OTHER EQUITY ITEMS 33
14. REVENUE AND COST OF SALES 34
15. OTHER OPERATING INCOME AND EXPENSES 35
16. FINANCIAL INCOME 35
17. FINANCIAL EXPENSES35
18. GAIN/(LOSS) ON NET MONETARY POSITION 36
19. EARNINGS PER SHARE36
20. FINANCIAL LIABILITIES 37
21. FOREIGN EXCHANGE POSITION39
22. EVENTS AFTER THE REPORTING PERIOD 45

CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS OF 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

Note
References
Not Reviewed
31 March
2025
Audited
31 December
2024
ASSETS
Current Assets 111.661.175 116.797.665
Cash and Cash Equivalents 3 12.832.115 18.311.472
Trade Receivables 5 27.681.227 31.208.841
From Related Parties 4 14.317.623 13.916.652
From Third Parties 13.363.604 17.292.189
Other Receivables 3.173.386 2.735.557
From Third Parties 3.173.386 2.735.557
Inventories 6 46.501.111 47.846.295
Prepaid Expenses 7 17.446.685 13.440.959
From Related Parties 4 2.514.291 2.104.707
From Third Parties 14.932.394 11.336.252
Other Current Assets 4.026.651 3.254.541
Non-Current Assets 158.384.606 150.432.560
Financial Investments 8.902.180 8.903.442
Trade Receivables 5 62.929.302 60.511.468
From Related Parties 4 43.651.185 44.179.971
From Third Parties 19.278.117 16.331.497
Other Receivables 12.655 13.096
From Third Parties 12.655 13.096
Equity Accounted Investments 1.364.046 1.466.330
Property, Plant and Equipment 8 41.527.633 41.173.514
Intangible Assets 8 26.371.939 24.028.271
Prepaid Expenses 7 3.828.249 4.114.914
From Related Parties 4 1.282.346 1.460.466
From Third Parties 2.545.903 2.654.448
Deferred Tax Assets 10 12.504.809 8.968.029
Other Non-Current Assets 943.793 1.253.496
TOTAL ASSETS 270.045.781 267.230.225

CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS OF 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

Not Reviewed Audited
Note 31 March 31 December
References 2025 2024
LIABILITIES
Current Liabilities 74.403.620 76.781.482
Short-term Financial Liabilities 20 6.036.829 14.929.791
Short-term Portion of Long-term Financial Liabilities 20 26.736.849 10.203.729
Trade Payables 5 13.735.116 21.749.036
To Related Parties 4 1.480.399 2.706.034
To Third Parties 12.254.717 19.043.002
Employee Benefit Obligations 3.437.099 3.896.856
Other Payables 333.026 603.765
To Related Parties 4 -- 374.607
To Third Parties 333.026 229.158
Government Grants and Incentives 66.034 72.679
Deferred Income 7 15.314.511 14.313.187
To Related Parties 4 5.516.184 6.678.940
To Third Parties 9.798.327 7.634.247
Short-term Provisions 8.726.032 10.973.963
For Employee Benefits 12 1.513.519 3.365.633
Other 9 7.212.513 7.608.330
Other Current Liabilities 18.124 38.476
Non-Current Liabilities 37.919.885 34.864.622
Long-term Financial Liabilities 20 171.730 10.705.550
Other Payables 16.957 21.243
To Third Parties 16.957 21.243
Deferred Income 7 27.523.331 13.018.803
To Related Parties 4 16.036.808 7.709.024
To Third Parties 11.486.523 5.309.779
Long-term Provisions 10.186.257 11.074.804
Long-term Provisions for Employee Benefits 12 1.082.518 1.157.157
Other 9 9.103.739 9.917.647
Other Non-Current Liabilities 21.610 44.222

CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS OF 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

Not Reviewed Audited
Note 31 March 31 December
References 2025 2024
EQUITY 157.722.276 155.584.121
Equity Attributable to Equity Holders of the Parent 156.696.703 154.417.223
Share Capital 13 4.560.000 4.560.000
Inflation Adjustments on Share Capital Differences 13 27.093.175 27.093.175
Share Premiums 23.118.473 23.118.473
Other Comprehensive Income / (Expense) that will not be
Reclassified to Profit or (Loss) 3.650.773 3.650.773
Gain on Revaluation of Property, Plant and Equipment 5.056.916 5.056.916
Gain/ Loss on Remeasurement of Defined Benefit Plans (1.406.143) (1.406.143)
Other Cumulative Comprehensive Income / (Expense) will be
Reclassified to Profit/Loss (663.090) (667.754)
Gain (Loss) on Financial Assets That Fair Value Difference
Reflect in Other Comprehensive income (539.196) (539.196)
Cumulative Translation Adjustments (123.894) (128.558)
Restricted Reserves 13 5.589.425 5.589.425
Retained Earnings 91.073.131 74.234.875
Net Profit for the Year 2.274.816 16.838.256
Non-Controlling Interests 1.025.573 1.166.898
TOTAL LIABILITIES AND EQUITY 270.045.781 267.230.225

CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS and OTHER COMPREHENSIVE INCOME FOR THE THREE-MONTH PERIOD ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

Not Audited
Note 1 January
31 March
1 January
31 March
References 2025 2024
PROFIT OR LOSS
Revenue
14 22.790.773 20.907.611
Cost of Sales (-) 14 (15.969.400) (14.857.768)
GROSS PROFIT 6.821.373 6.049.843
General Administrative Expenses (-) (1.417.024) (1.429.172)
Marketing Expenses (-) (590.256) (467.339)
Research and Development Expenses (-) (842.833) (413.244)
Other Operating Income 15 10.228.863 7.992.979
Other Operating Expenses (-) 15 (6.793.644) (5.542.739)
OPERATING PROFIT 7.406.479 6.190.328
Income From Investing Activities 34.292 20.755
Shares of Profit of Equity Accounted Investees (100.796) (37.514)
OPERATING PROFIT BEFORE FINANCIAL EXPENSE 7.339.975 6.173.569
Financial Income 16 844.753 371.869
Financial Expense (-) 17 (3.294.387) (2.518.588)
Monetary Gain/(Loss) 18 (7.025.872) (4.763.331)
PROFIT BEFORE TAX FROM CONTINUING OPERATIONS (2.135.531) (736.481)
Tax Income from Continuing Operations 10 4.269.022 2.447.474
- Current Corporate Tax Expense(-) (87.700) (6.714)
- Deferred Tax Income 4.356.722 2.454.188
PROFIT FOR THE PERIOD FROM CONTINUING
OPERATIONS
2.133.491 1.710.993
Profit for the Period Attributable to 2.133.491 1.710.993
Non-Controlling Interest (141.325) (227.657)
Owners of the Company 19 2.274.816 1.938.650
2.133.491 1.710.993
Earnings for per 100 Shares (in full kuruş) 19 49,89 42,51

CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS and OTHER COMPREHENSIVE INCOME FOR THE THREE-MONTH PERIOD ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

Audited
1 January- 1 January
Note 31 March 31 March
References 2025 2024
PROFIT FOR THE YEAR 2.133.491 1.710.993
OTHER COMPREHENSIVE INCOME
Items that may be Reclassified Subsequently to Profit or
Loss 4.664 (61.389)
Cumulative Translation Adjustments 4.664 (61.389)
OTHER COMPREHENSIVE INCOME 4.664 (61.389)
TOTAL COMPREHENSIVE INCOME 2.138.155 1.649.604
Total Comprehensive Income Attributable to
Non-Controlling Interest (141.325) (227.657)
Owners of the Company 2.279.480 1.877.261
2.138.155 1.649.604

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

Other Comprehensive Income /
Expense that will not to be
Reclassified Subsequently to
Profit or Loss
Other Comprehensive Income
/ Expense that may not to be
Reclassified Subsequently to
Profit or Loss
Retained Earnings
Share Inflation
Adjustments
on Share
Share
Issuance
Premiums/
Revaluation Remeasurement
of Defined
Gain (Loss)
on Financial
Assets That
Fair Value
Difference
Reflect in
Other
Comprehensi
Translation Restricted Retained Net
Profit/(Loss)
Equity
Attributable to
Owners of the
Non
Controlling
Capital Capital (Discounts) Reserves Benefit Plans ve income Reserves Reserves Earnings for the Year Company Interests Equity
Balance as of 1 January 2024 4.560.000 27.093.147 23.118.473 4.616.794 (1.119.598) -- 89.401 5.533.288 63.267.154 11.585.109 138.743.768 1.699.270 140.443.038
Transfers -- -- -- -- -- -- -- -- 11.585.109 (11.585.109) -- -- --
Capital Increase -- -- -- -- -- -- -- -- -- -- -- -- --
Total Comprehensive Income -- -- -- -- -- -- (61.389) -- -- 1.938.650 1.877.261 (227.657) 1.649.604
Balance as of 31 March 2024
(Closing Balance)
4.560.000 27.093.147 23.118.473 4.616.794 (1.119.598) -- 28.012 5.533.288 74.852.263 1.938.650 140.621.029 1.471.613 142.092.642
Balance as of 1 January 2025 4.560.000 27.093.175 23.118.473 5.056.916 (1.406.143) (539.196) (128.558) 5.589.425 74.234.875 16.838.256 154.417.223 1.166.898 155.584.121
Transfers -- -- -- -- -- -- -- -- 16.838.256 (16.838.256) -- -- --
Capital Increase -- -- -- -- -- -- -- -- -- -- -- -- --
Total Comprehensive Income -- -- -- -- -- -- 4.664 -- -- 2.274.816 2.279.480 (141.325) 2.138.155
Balance as of 31 March 2025
(Closing Balance) 4.560.000 27.093.175 23.118.473 5.056.916 (1.406.143) (539.196) (123.894) 5.589.425 91.073.131 2.274.816 156.696.703 1.025.573 157.722.276

CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

Not Reviewed Not Reviewed
1 January 1 January
Note 31 March 31 March
References 2025 2024
A.Cash Flows from Operating Activities 4.228.300 (4.103.979)
Profit for the Period 2.133.491 1.710.993
Adjustments to Reconcile Profit for the Period 1.635.940 (806.729)
- Adjustments for Depreciation and Amortization Expense 8 1.171.162 952.639
- Adjustments for Impairment Loss (Reversal of Impairment Loss) 41.123 (30.966)
Adjustments for Impairment Loss (Reversal of Impairment Loss) of Receivables 5 (2.127) (8.104)
Adjustments for Impairment Loss (Reversal of Impairment Loss) of Inventories 6 43.250 (22.862)
- Adjustments for Provisions 331.918 (852.649)
Adjustments for (Reversal of) Provisions Related with Employee Benefits 12 (1.064.683) (975.917)
Adjustments for (Reversal of) Lawsuit and/or Penalty Provisions 1.121.799 (357.678)
Adjustments for (Reversal of) Warranty Provisions 581.169 484.484
Adjustments for (Reversal of) Other Provisions (306.367) (3.538)
- Adjustments for Interest (Income) Expenses (363.426) (629.845)
Adjustments for Interest Income (993.468) (1.222.062)
Adjustments for Interest Expense 630.042 592.217
- Adjustments for Retained Profit of Equity Accounted Investees 100.796 37.514
- Adjustments for Tax (Income)/Expenses (4.269.022) (2.447.474)
- Other Adjustments for which Cash Effects are Investing or Financing Cash Flow 2.771.475 1.439.981
- Other Adjustments to Reconcile Profit (Loss) 1.851.914 724.071
Changes in Working Capital 1.999.059 (4.064.128)
- Decrease (Increase) in Trade Receivables 9.521.388 7.303.791
- Decrease (Increase) in Other Receivables Related with Operations (437.389) (236.103)
- Decrease (Increase) in Inventories 6 1.430.036 1.122.177
- Decrease (Increase) in Prepaid Expenses 7 (3.869.332) (1.245.378)
- Increase (Decrease) in Trade Payables 5 (7.195.989) (3.250.177)
- Increase (Decrease) in Employee Benefit Obligations 12 (459.756) 1.229.180
- Adjustments for Stage of Completion of Construction or Service Contracts in
Progress (1.419.211) (5.055.776)
- Increase (Decrease) in Other Operating Payables (275.025) (336.917)
- Increase (Decrease) in Government Grants and Subsidies (6.645) 300
- Increase (Decrease) in Deferred Income 7.885.539 (6.043.052)
- Adjustments Related to Monetary Gain/ Losses (2.798.503) 3.344.309
- Other Increase (Decrease) in Working Capital (376.054) (896.482)
Cash Flows From Operations 5.768.490 (3.159.864)
Payments Related with Provisions for Employee Benefits 12 (448.554) (144.457)
Payments Related with Other Provisions (1.003.936) (802.432)
Income Taxes Refund (Paid) (87.700) 2.774
B.Cash Flows From Investing Activities (5.775.575) (3.337.579)
Proceeds from Sales of Property, Plant, Equipment and Intangible Assets 41.786 213.706
Purchase of Property, Plant and Equipment 8 (1.546.865) (938.112)
Purchase of Intangible Assets 8 (4.406.919) (2.696.440)
Other Cash Inflows (Outflows) 136.423 83.267
C.Cash Flows From Financing Activities (2.388.390) 2.527.297
Proceeds from Borrowings 6.686.267 9.702.865
Repayments of Borrowings (9.074.657) (7.175.568)
NET INCREASE/DECREASE IN CASH AND CASH EQUIVALENTS BEFORE
EFFECT OF EXCHANGE RATE CHANGES (A+B+C)
(3.935.665) (4.914.261)
D. EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS 84.296 41.411
E. MONETARY GAİN/LOSS EFFECT ON CASH AND CASH EQUİVALENTS (1.674.208) (1.375.115)
NET INCREASE/DECREASE IN CASH AND CASH EQUIVALENTS (A+B+C+D+E) (5.525.577) (6.247.965)
F.CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD 18.311.472 10.489.604
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD (A+B+C+D+E+F) 3 12.785.895 4.241.639

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

1. ORGANIZATION AND OPERATIONS OF THE GROUP

ASELSAN Elektronik Sanayi ve Ticaret Anonim Şirketi ("the Company") was established in order to engage principally in research, development, engineering, production, tests, assembly, integration and sales, after sales support, consultancy and trading activities, to provide and conduct all sorts of activities for project preparation, engineering, consultancy, service providing, training, contracting, construction, publishing, trading, operation and internet services regarding various software, equipment, system, tools, material and platforms in the fields of electrical, electronics, microwave, electro-optics, guidance, computer, data processing, encryption, security, mechanics, chemistry and related areas within the army, navy, air force and aerospace applications to all institutions, organizations, companies and individual consumers.

The Company was established at the end of 1975 as a corporation by Turkish Land Forces Foundation. The Company commenced its production activities in Macunköy Facilities in early 1979.

As of the reporting date, the Company has been organized under five divisions under the Vice Presidential Sector with regard to investment and production requirements of projects. These divisions comprise Communication and Information Technologies Vice Presidency (''HBT''), Radar and Electronic Warfare Systems Vice Presidency (''REHİS''), Integrated Defence Systems Technologies Vice Presidency (''SST'') and Microelectronics and Electro-Optics Vice Presidency (''MEOS''), Avionics and Guidance Systems Vice Presidency ("AGS") and Transportation, Security, Energy, Automation and Healthcare Systems Vice Presidency (''UGES'').

In addition to the Vice Presidencies above, the Company organization also includes five Vice Presidencies to fulfil the planning, monitoring and analyzing functions: Financial Management Vice Presidency, Corporate Management Vice Presidency, Technology and Strategy Management Vice Presidency, Business Development and Marketing Vice Presidency, Supply Chain Management Vice Presidency and Malatya Campus Directorate. In addition to these, there are also Legal Affairs and Office of the Private Secretary.

The Internal Audit Department and Board of Directors Planning and Coordination Management have been established under the Board of Directors.

The Company maintains production and engineering operations in Ankara, Macunköy, Akyurt and Gölbaşı campuses and engineering operations in Hacettepe Teknokent, Teknopark İstanbul, Aselsan Temelli Campus and Aselsan Malatya Campus. Headquarters is located in Ankara Macunköy.

Turkish Armed Forces Foundation ("TSKGV") is the main shareholder of the Company which holds 74,20 percent of the capital and maintains control of the Company. TSKGV was established on 17 June 1987 with the law number 3388, in order to manufacture or import guns, equipment and appliances needed for Turkish Armed Forces.

The Company is registered to Capital Markets Board of Türkiye ("CMB") and its shares have been quoted in Borsa İstanbul Anonim Şirketi ("BIST") since 1990. As of 31 March 2025, 25,80 percent of the Company's shares are publicly traded (31 December 2024: 25,80 percent) (Note 13).

The Company's trade registry address is Mehmet Akif Ersoy Mahallesi İstiklal Marşı Caddesi No:16 06200 Yenimahalle/Ankara. The average number of personnel employed by the Group as of 31 March 2025 is 13.232 (31 December 2024: 12.014).

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

1. ORGANIZATION AND OPERATIONS OF THE GROUP (continued)

The Company's consolidated subsidiaries are ASELSAN Baku ("ASELSAN Baku"), Aselsan Sivas Hassas Optik San. Tic. A.Ş. (" ASELSAN Optik"), Mikroelektronik Ar-Ge Tasarım ve Ticaret Ltd. Co. ("Mikro AR-GE"), ASELSANNET Elektronik ve Haberleşme Sistemleri Sanayi Ticaret İnşaat ve Taahhüt Ltd. Co. ("ASELSANNET"), Aselsan Konya Silah Sistemleri Anonim Şirketi ("ASELSAN Konya"), ASELSAN Malaysia Sdn. Bhd. ("ASELSAN Malaysia"), BITES Savunma Havacılık ve Uzay Teknolojileri Yazılım A.Ş. ("BITES"), Aselsan Global Dış Ticaret ve Pazarlama A.Ş. ("ASELSAN Global"), ASELSAN UKRAINE LLC. ("ASELSAN Ukrayna"), ASELSAN Latin Amerika SpA ("ASELSAN Latin Amerika") and ASELSAN Technologies Limited ("ASELSAN UAE"). They are collectively referred as the "Group" in the accompanying notes.

The Company has five branch offices; Aselsan Elektronik Sanayi ve Ticaret Anonim Şirketi EP Co. (''ASELSAN South Africa''), ASELSAN Balkans (''ASELSAN Balkans''), ASELSAN Kıbrıs İleri Araştırma Merkezi ("ASELSAN N.Cyprus"), ASELSAN Elektronik Sanayi ve Ticaret A.Ş. Katar ("ASELSAN Qatar") and ASELSAN Elektronik Sanayi ve Ticaret A.Ş. Poland ("ASELSAN Poland) located in Republic of South Africa, Macedonia, Turkish Republic of Northern Cyprus ("TRNC"), Qatar and Poland, respectively. The branches are also included in the consolidated financial statements.

2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS

2.1 The Basis of Presentation

Statement of Compliance to TFRS

The accompanying consolidated financial statements are prepared in accordance with the requirements of CMB Communiqué Serial II, No: 14.1 "Basis of Financial Reporting in Capital Markets" ("Communiqué"), which were published in the Official Gazette No: 28676 on 13 June 2013 and in accordance with the Turkish Financial Reporting Standards ("TFRS") and Interpretations that have been put into effect by the Public Oversight Accounting and Auditing Standards Authority ("POA").

The consolidated financial statements has been presented with examples of Financial Statement by the POA. All reports have suited the TFRS formats. The consolidated financial statements are prepared according to historical cost accounting except for the revaluation of land and financial instruments. The consolidated condensed financial statements of the Group for the three months ended 31 March 2025 have been prepared in accordance with TAS 34 Interim Financial Reporting. The interim condensed financial statements do not contain all the information and explanations that should be included in the annual financial statements and should be read together with the annual consolidated financial statements of the Group as of 31 March 2025.

Approval of the Consolidated Financial Statements

These consolidated financial statements have been approved for issue by the Board of Directors with the resolution number 1265 on 29 April 2025. There is no authority other than General Assembly and legal entities has the right to amend the consolidated financial statements.

Functional Currency

The individual financial statements of each Group entity are presented in the currency of the primary economic environment ("Functional Currency") in which the entity operates. The Company's reporting currency is Turkish Lira (''TL''). For the purpose of the consolidated financial statements, the results and financial position of each entity are expressed in TL, which is the functional, and presentation currency of the Company for the consolidated financial statements. Amounts are expressed in thousands of TL or Foreign Currency unless otherwise stated. Kuruş, Turkish Currency subunit and 1 TL is equal to 100 Kuruş.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.) 2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.1 The Basis of Presentation (continued)

Preparation of Financial Statements in Hyperinflationary Periods

With the decision taken on March 17, 2005, the CMB has announced that, effective from January 1, 2005, the application of inflation accounting is no longer required for companies operating in Turkey and preparing their financial statements in accordance with CMB Accounting Standards and therefore the preparation and presentation of financial statements in accordance with International Accounting Standard 29 "Financial Reporting in Hyperinflationary Economies" is no longer required.

On November 23, 2023, Public Oversight Accounting and Auditing Standards Authority ("POA") announced the application of inflation accounting in Turkey and according to the announcement, financial statements of entities applying TFRS for the annual reporting period ending on or after December 31, 2023 should be presented as adjusted for the effects of inflation in accordance with the related accounting principles in TAS 29. As of the date of these financial statements, inflation adjustment has been made in accordance with TAS 29 while preparing the financial statements dated 31 March 2025.

IAS 29 requires that financial statements prepared in the currency of a hyperinflationary economy be stated in terms of the measuring unit current at the balance sheet date and that corresponding figures for previous periods be restated in the same terms using the general price index. One of the conditions that require the application of TAS 29 is a three-year cumulative inflation rate of approximately 100% or more. In Turkey, based on the consumer price index ("CPI") published by the Turkish Statistical Institute ("TURKSTAT"), the cumulative rate was 250% for the three-year period ended 31 March 2025 (31 December 2024: %291).

Adjustments for inflation have been calculated based on the coefficients calculated using the Consumer Price Index in Turkey published by the Turkish Statistical Institute. As of 31 March 2025, the indices and coefficients used in the restatement of the accompanying financial statements are as follows:

Period Index Correction Coefficient
31 March 2025 2.684,55 1
31 December 2024 2.684,55 1,10063
31 March 2024 2.139,47 1,38104
31 December 2023 1.859,38 1,58907

The main lines of TAS 29 indexation transactions are as follows:

As of the balance sheet date, all items other than those stated in terms of current purchasing power are restated by using the relevant consumer price index coefficients. Prior year amounts are restated in the same way. Financial statements of previous reporting periods have been restated to reflect the current purchasing power of money at the latest balance sheet date. The current period restatement factor has been applied to the prior period financial statements.

Monetary assets and liabilities are not restated because they are expressed in terms of the purchasing power of money at the balance sheet date. Monetary items are cash and items to be received or paid in cash.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.2 The Basis of Presentation (continued)

Non-monetary assets and liabilities are restated by reflecting the changes in the general price index from the date of acquisition or initial recognition to the balance sheet date in their acquisition costs and accumulated amortization amounts. Accordingly, property, plant and equipment, intangible assets, right-of-use assets and similar assets are restated to their acquisition values, which do not exceed their market values. Depreciation has been restated in a similar manner. Amounts included in shareholders' equity have been restated by applying the consumer price indices for the periods in which such amounts were contributed to or arose within the Company.

All items in the income statement, except for the effects of non-monetary items in the balance sheet on the income statement, have been restated by applying the multiples calculated over the periods when the income and expense accounts were initially recognized in the financial statements.

The gain or loss arising on the net monetary position as a result of general inflation is the difference between the restatement adjustments to non-monetary assets, equity items and income statement accounts. This gain or loss on the net monetary position is included in net profit.

All items presented in the statement of cash flows are restated for the effects of inflation in the measuring unit current at the end of the reporting period. The effect of inflation on cash flows from operating, investing and financial activities is attributed to the related item and the monetary gain or loss on cash and cash equivalents is presented separately.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.) 2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.1 The Basis of Presentation (continued)

Basis of Consolidation

Subsidiaries:

The details of the subsidiaries of the Group are as follows:

Group's proportion of
ownership and voting power
held (%)
Functional 31 March 31 December
Subsidiaries Location Currency 2025 2024 Main Activity
ASELSANNET Türkiye TL 100 100 Communication systems
ASELSAN Baku Azerbaijan AZN 100 100 Marketing and sales of
the group products
ASELSAN Global Türkiye TL 100 100 Export
ASELSAN Optik Türkiye TL 80 80 Sensitive optic
technologies
Mikro AR-GE Türkiye TL 85 85 Microelectronic R&D
projects
ASELSAN Malaysia Malaysia MYR 100 100 Remote controlled
weapon systems
ASELSAN Konya Türkiye TL 51 51 Weapon and weapon
systems
BITES Türkiye TL 100 100 Defense, Aerospace,
Space Technologies,
Software
ASELSAN Ukraine Ukraine UAH 100 100 Marketing and sales of
the group products
ASELSAN Latin
Amerika
Chile CLP 100 100 Marketing and business
development
ASELSAN UAE BAE AED 100 100 Marketing and business
development

The consolidated financial statements include the financial statements of the Company and its subsidiaries. Control is achieved when the Company:

  • has power over the investee;
  • is exposed, or has rights, to variable returns from its involvement with the investee; and
  • has the ability to use its power to affect its returns

The Company reassesses whether or not it controls an investee when if facts and circumstances arise there are changes to one or more of the three elements of control listed above.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.2 The Basis of Presentation (continued)

Basis of Consolidation (continued)

Subsidiaries (continued):

Even though the Company has voting rights less than a majority, if it has ability to manage the operation of the investee unintentionally, then the Group assess that it has control over that investee.

The Company considers all relevant facts and circumstances in assessing whether or not the Company's voting rights in an investee are sufficient to give it power, including:

  • comparison of voting rights of the Group and the others,
  • potential voting rights held by the Group, and others,
  • rights arising from contractual arrangements; and

• any additional facts and circumstances that indicate the Group has, or does have, the current ability to direct the relevant activities at the time that decisions need to be made (including voting patterns at previous shareholders' meeting).

The financial statements of subsidiaries are included in the consolidated financial statements from the date on which control commences until the date on which control ceases. Income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated statement of profit or loss and other comprehensive income from the date the Company gains control until the date when the Company ceases to control the subsidiary.

Each item of profit or loss and other comprehensive income are attributed to the owners of the Company and to the non-controlling interests. Total comprehensive income of subsidiaries is attributed to the owners of the Company and to the non-controlling interests even if results in the non-controlling interests having a deficit balance.

When necessary, adjustments are made to the financial statements of subsidiaries to align with the Group accounting policies and the Group's accounting policies.

All intragroup balances, equity, income and expenses, profits and losses and cash flows relating to transactions between members of the Group are eliminated during consolidation.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.1 The Basis of Presentation (continued)

Basis of Consolidation (continued)

Joint Ventures

The details of the Group's interests in joint ventures as of 31 March 2025 and 31 December 2024 are as follows:

Group's proportion of
ownership and voting power
held (%)
Joint Ventures Principal Activity Country of
establishment
and operation
31 March
2025
31 December
2024
Mikro Nano Teknolojileri Sanayi
ve Ticaret Anonim Şirketi
(''ASELSAN Bilkent'')
Production of micro and nano sized devices
which contains semi-conductive and similar
technological materials
Türkiye 50 50
International Golden Group
("IGG") ASELSAN Integrated
Systems LLC ("IGG ASELSAN")
Manufacturing, testing, maintenance-repair
and marketing of remote control system
United Arab
Emirates
49 49
Kazakhstan ASELSAN Engineering
LLP ("ASELSAN Kazakhstan")
Manufacturing, development and
maintenance repair of electronic devices and
systems
Kazakhstan 49 49
ASELSAN Middle East PSC
("ASELSAN Jordan")
Production, sales and technical maintenance
service of electronic and electro-optic devices
and systems
Jordan 49 49
TÜYAR Mikroelektronik Sanayi ve
Ticaret Anonim Şirketi ("TÜYAR")
Production of micro and nano-sized devices
containing semiconductor
Türkiye 51 51
BARQ QSTP LLC. ("BARQ QSTP
LLC.")
Command and control systems, thermal and
night vision camera, crypto, remote-controlled
weapon systems
Qatar 48 48
Teknohab Teknoloji Geliştirme
Bölgesi Yönetici Anonim Şirketi
("TEKNOHAB")
Manage and operate the technology
development zone
Türkiye 13 13
EHSİM Elektronik Harp Sistemleri
Müh. Tic. A.Ş.("EHSİM")
Electronic warfare systems, tactical command
and control systems & decoy target systems
Türkiye 50 50
TR Eğitim ve Teknoloji A.Ş.
("TR Eğitim")
Human Resources Studies, consultancy and
training activities, certification activities,
training software activities, publishing
activities
Türkiye 35 35
İstanbul Finans ve Teknoloji
Merkezi ("İFTÜ")
To establish infrastructure activities for the
development of the financial technology
ecosystem
Türkiye 44 44
Adıyaman Kablo ve Konnektör
A.Ş. ("Adıyaman Kablo")
Production, design and sale of cables,
connectors, cabling and similar products and
technologies
Türkiye 15 15
ULAK Haberleşme A.Ş. ("ULAK") Design, development and engineering
activities of broadband communication devices
and mobile communication systems
Türkiye 51 51

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.) 2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.1 The Basis of Presentation (continued)

Basis of Consolidation (continued)

Joint Ventures (continued):

A joint venture is a joint arrangement whereby the parties that have joint control of the arrangement have rights to the net assets of the joint arrangement. Joint control is the contractually agreed sharing of control of an arrangement, which exists only when decisions about the relevant activities require unanimous consent of the parties sharing control.

The Group's joint ventures; EHSİM established in 1998, IGG ASELSAN and ASELSAN Kazakhstan established in 2011, ASELSAN Jordan established in 2012 and ASELSAN Bilkent established in 2014, TÜYAR and ULAK established in 2017, TEKNOHAB established in 2018, TR Eğitim established in 2019, İFTÜ established in 2022, and Adıyaman Kablo established in 2024 were included in the condensed consolidated financial statements by using the equity method. Since BARQ QSTP LLC is at micro level, there is no material consolidation effect on the Group's financial statements.

2.2 Comparative Information and Restatement of Prior Period Consolidated Financial Statements

In order to determine the financial position and performance trends, the Group's consolidated financial statements are presented comparatively with the corresponding figures. For the purpose of having consistency with the current term's presentation of consolidated financial statements, comparative information is reclassified and significant differences are explained if necessary.

2.3 Accounting Policies, Changes in Accounting Estimates and Errors

Significant changes in accounting policies and errors are applied retrospectively and prior period financial statements are restated, changes in accounting estimates are reflected to the financial in current period profit/loss.

When change in estimate in accounting policies are related with only one period, changes are applied on the current period but if the estimated changes are for the following periods, changes are applied both on the current and following periods prospectively.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.) 2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.4 New and Revised Turkish Accounting Standards

The accounting policies adopted in preparation of the consolidated financial statements as at 31 March 2025 are consistent with those of the previous financial year, except for the adoption of new and amended TFRS and TFRS interpretations effective as of 1 January 2025 and thereafter. The effects of these standards and interpretations on the Group's financial position and performance have been disclosed in the related paragraphs.

a) The new standards, amendments and interpretations which are effective as at 1 January 2025 are as follows:

Amendments to IAS 21 - Lack of Exchangeability;

Effective from annual periods beginning on or after 1 January 2025. An entity is impacted by the amendments when it has a transaction or an operation in a foreign currency that is not exchangeable into another currency at a measurement date for a specified purpose. A currency is exchangeable when there is an ability to obtain the other currency (with a normal administrative delay), and the transaction would take place through a market or exchange mechanism that creates enforceable rights and obligations. The Group assessed that there is no impact on its consolidated financial statements resulting from the amendments of IAS 21.

b) The new amendments that are issued by the International Accounting Standards Board (IASB) but not issued by POA

The following amendments which are issued by IASB but not yet adapted/issued by POA. Therefore, they do not constitute part of TFRS. The Group will make the necessary changes to its consolidated financial statements after the amendments are issued and become effective under TFRS.

IFRS 18 Presentation and Disclosure in Financial Statements;

Effective from annual periods beginning on or after 1 January 2027. This is the new standard on presentation and disclosure in financial statements, with a focus on updates to the statement of profit or loss. The key new concepts introduced in IFRS 18 relate to:

  • The structure of the statement of profit or loss;
  • Required disclosures in the financial statements for certain profit or loss performance measures that are reported outside an entity's financial statements (that is, management defined performance measures); and
  • Enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes in general.

IFRS 19 Subsidiaries without Public Accountability: Disclosures;

Effective from annual periods beginning on or after 1 January 2027. Earlier application is permitted. This new standard works alongside other IFRS Accounting Standards. An eligible subsidiary applies the requirements in other IFRS Accounting Standards except for the disclosure requirements and instead applies the reduced disclosure requirements in IFRS 19. IFRS 19's reduced disclosure requirements balance the information needs of the users of eligible subsidiaries' financial statements with cost savings for preparers. IFRS 19 is a voluntary standard for eligible subsidiaries. A subsidiary is eligible if:

  • It does not have public accountability; and
  • It has an ultimate or intermediate parent that produces consolidated financial statements available for public use that comply with IFRS Accounting Standards.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.) 2. BASIS OF PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS (continued)

2.4 New and Revised Turkish Accounting Standards (continued)

Amendments to the Classification and Measurement of Financial Instruments

Amendments to the Classification and Measurement of Financial Instruments was issued in May 2024 in response to feedback received as part of the post-implementation review of the classification and measurement requirements in IFRS 9 Financial Instruments and related requirements in IFRS 7 Financial Instruments: Disclosures. effective from 1 January 2026.

The amendments specify:

• when a financial liability settled using an electronic payment system can be deemed to be discharged before the settlement date;

• how to assess the contractual cash flow characteristics of financial assets with contingent features when the nature of the contingent event does not relate directly to changes in basic lending risks and costs; and

• new or amended disclosure requirements relating to investments in equity instruments designated at fair value through other comprehensive income and financial instruments with contingent features that do not relate directly to basic lending risks and costs.

Annual Improvements to IFRS Accounting Standards—Volume 11

Annual Improvements to IFRS Accounting Standards—Volume 11 contains the following amendments effective from 1 January 2026::

IFRS 1 First-time Adoption of International Financial Reporting Standards

Hedge accounting by a first-time adopter

IFRS 7 Financial Instruments: Disclosures

Gain or loss on derecognition

Guidance on implementing IFRS 7 Financial Instruments: Disclosures

  • Introduction
  • Disclosure of deferred difference between fair value and transaction price
  • Credit risk disclosures

IFRS 9 Financial Instruments

  • Derecognition of lease liabilities
  • Transaction price

IFRS 10 Consolidated Financial Statements

• Determination of a 'de facto agent'

IAS 7 Statement of Cash Flows

• Cost method

Contracts Referencing Nature-dependent Electricity

Contracts Referencing Nature-dependent Electricity amends IFRS 9 Financial Instruments and IFRS 7 Financial Instruments effective from 1 January 2026: Disclosures to more faithfully reflect the effects of contracts referencing nature-dependent electricity on an entity's financial statements.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

3. CASH AND CASH EQUIVALENTS

31 March 31 December
2025 2024
Cash 1.125 1.171
Bank
- Time deposit 12.601.730 16.989.989
- Demand deposit 78.980 1.155.838
Other 104.060 164.474
Cash and cash equivalents on the cash flow statement 12.785.895 18.311.472
Interest income accruals 46.220 --
12.832.115 18.311.472

As of 31 March 2025, the Group has time deposits denominated in foreign currencies with maturities on April 2025 (31 December 2024: January 2025), with the interest rates between 3,25 percent and 4,50 percent (31 December 2024: 0,50 percent and 3 percent) amounting to TL 2.112.219 (31 December 2024: TL 2.061.578) in several banks.

As of 31 March 2025, the Group has time deposits denominated in TL terms with maturities on April 2025 (31 December 2024: January 2025) with the interest rates between 42,50 percent and 46,00 percent (31 December 2024: 48,50 percent and 49,25 percent) amounting to TL 10.489.511 (31 December 2024: TL 14.928.411) in several banks.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

4. RELATED PARTY DISCLOSURES

Transactions between the Company and its subsidiaries which are related parties of the Company have been eliminated on consolidation, therefore have not been disclosed in this note.

The trade receivables from related parties generally arise from sales activities with maturitiy of 1 year.

The trade payables to related parties generally arise from the purchase activities with maturities of 1-4 months.

Total amount of salaries and other short-term benefits paid for key management for the period ended 31 March 2025 is approximately TL 119.986 (The vast majority consists of paid wages and benefits.) (31 March 2024: TL 83.864).

The details of transactions between the Group and other related parties are disclosed in the following pages.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

4. RELATED PARTY DISCLOSURES (continued)

31 March 2025
Receivables Payables
Short-term Long-term Short-term Long-term
Prepaid Other Prepaid Deferred Other Deferred
Balances with related parties Trading Expenses Receivables Trading Expenses Trading Income Payables Trading Income
Main shareholder
TSKGV 86 -- -- -- -- -- -- -- -- --
Main shareholder's subsidiaries and associates
Hava Elektronik San. ve Tic. Anonim Şirketi (''HAVELSAN'') 52.510 693.652 -- 33.063 167.854 276.449 25.180 -- -- 1.143.340
HAVELSAN Teknoloji Radar San. ve Tic. Anonim Şirketi ("HTR") 41.438 275.827 -- -- 59.936 437.351 31.283 -- -- --
İşbir Elektrik Sanayii Anonim Şirketi ("İŞBİR") -- 220.236 -- -- 39.607 137.855 -- -- -- --
NETAŞ Telekomünikasyon Anonim Şirketi ("NETAŞ") 6 8.303 -- -- 17.170 77.171 -- -- -- --
Savunma Teknolojileri Mühendislik ve Ticaret Anonim Şirketi
("STM") 118.559 12.881 -- 878.539 -- 29.291 22.186 -- -- 648.500
Tusaş Motor Sanayii Anonim Şirketi ("TEI") 12.719 -- -- -- -- -- -- -- --
Türk Havacılık ve Uzay Sanayi ve Ticaret Anonim Şirketi ("TUSAŞ") 3.880.838 -- -- 4.383.516 -- 1.235 231.707 -- -- 599.123
Financial Instruments
ASPİLSAN Enerji Sanayi ve Ticaret Anonim Şirketi ("ASPİLSAN") 2 22.960 -- -- -- 7.584 7.035 -- -- --
Roket Sanayi ve Ticaret Anonim Şirketi ("ROKETSAN") 3.903.249 58.981 -- 459.522 863.838 129.178 460.283 -- -- 185.524
Joint ventures and its related parties
ASELSAN Bİlkent -- 286.946 -- -- 65.609 50.721 -- -- -- --
İhsan Doğramacı Bilkent Üniversitesi -- 6.170 -- -- -- 10.821 -- -- -- --
IGG 23.234 -- -- 3.038 -- -- 2.334 -- -- --
IGG ASELSAN 6.503 43.166 -- -- 3.627 26.685 -- -- -- --
ASELSAN Kazakhstan 323.906 -- -- 59.682 -- 308 1.381 -- -- --
ASELSAN Jordan 139.476 -- -- -- -- 27.935 4.090 -- -- 5.513
TÜBİTAK BİLGEM -- 100.567 -- -- 13.838 81.810 -- -- -- --
TÜBİTAK-UME -- 5.936 -- -- -- 3 -- -- -- --
TÜBİTAK BİLİMSEL TEKNOLOJİK ARAŞTIRMA 9.849 52.688 -- 224.323 1.029 7.877 7.553 -- -- 14.214
TÜBİTAK SAGE Savunma Sanayii 11.287 501.361 -- 4.359 49.021 82.518 1.624 -- -- --
Savunma Sanayi Başkanlığı ("SSB") 4.801.426 -- -- 37.605.143 -- -- 4.258.240 -- -- 13.424.093
SSTEK 3 -- -- -- -- -- 463.288 -- -- 16.501
EHSİM 539 162.638 -- -- 817 95.531 -- -- -- --
ULAK 991.993 2.374 -- -- -- -- -- -- -- --
TÜYAR -- 59.605 -- -- -- -- -- -- -- --
TR Eğitim -- -- -- -- -- 76 -- -- -- --
14.317.623 2.514.291 -- 43.651.185 1.282.346 1.480.399 5.516.184 -- -- 16.036.808

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

4. RELATED PARTY DISCLOSURES (continued)

31 December 2024
Receivables Payables
Short-term Long-term Short-term Long-term
Prepaid Other Prepaid Deferred Deferred
Balances with related parties Trading Expenses Receivables Trading Expenses Trading Income Other Payables1 Trading Income
Main shareholder
TSKGV -- -- -- -- -- -- -- 374.607 -- --
Main shareholder's subsidiaries and associates
Hava Elektronik San. ve Tic. Anonim Şirketi (''HAVELSAN'') 57.130 595.127 -- 16.309 227.954 930.880 6 -- -- 708.240
HAVELSAN Teknoloji Radar San. ve Tic. Anonim Şirketi ("HTR") 45.331 245.771 -- -- 56.721 580.197 13.044 -- -- --
İşbir Elektrik Sanayii Anonim Şirketi ("İŞBİR") -- 206.269 -- -- 46.335 85.030 -- -- -- --
NETAŞ Telekomünikasyon Anonim Şirketi ("NETAŞ") -- 9.030 -- -- 20.391 46.566 -- -- -- --
Savunma Teknolojileri Mühendislik ve Ticaret Anonim Şirketi
("STM") 151.688 22.811 -- 820.883 -- 20.164 -- -- -- 695.745
Tusaş Motor Sanayii Anonim Şirketi ("TEI") 48.266 -- -- -- -- -- -- -- -- --
Türk Havacılık ve Uzay Sanayi ve Ticaret Anonim Şirketi ("TUSAŞ") 4.441.847 -- -- 2.543.320 -- 15.556 395.359 -- -- --
Financial Instruments
ASPİLSAN Enerji Sanayi ve Ticaret Anonim Şirketi ("ASPİLSAN") -- 26.158 -- -- 5.312 21.092 5.170 -- -- --
Roket Sanayi ve Ticaret Anonim Şirketi ("ROKETSAN") 4.127.927 82.602 -- 432.874 914.461 511.432 568.279 -- -- 289.075
Joint ventures and its related parties
ASELSAN Bİlkent -- 270.686 -- -- 80.876 97.124 -- -- -- --
İhsan Doğramacı Bilkent Üniversitesi -- 6.847 -- -- -- 40 -- -- -- --
IGG 23.850 -- -- 3.344 -- -- 2.569 -- -- --
IGG ASELSAN 6.676 40.041 -- -- 3.992 26.665 -- -- -- --
ASELSAN Kazakhstan 328.677 -- -- 65.687 317 1.520 -- -- --
ASELSAN Jordan 135.433 -- -- -- 28.679 383 -- -- 6.068
TÜBİTAK BİLGEM -- 93.497 -- -- 15.284 111.045 -- -- -- --
TÜBİTAK-UME -- 2.745 -- -- 3 -- -- -- --
TÜBİTAK BİLİMSEL TEKNOLOJİK ARAŞTIRMA 10.850 50.186 -- 338.935 1.413 4.105 6.070 -- -- 15.183
TÜBİTAK SAGE Savunma Sanayii 33.049 216.322 -- 10.684 84.826 170.139 1.122 -- -- --
Savunma Sanayi Başkanlığı ("SSB") 3.479.405 -- 39.947.935 -- -- 5.246.496 -- -- 5.976.585
SSTEK 4 -- -- -- -- 438.922 -- -- 18.128
ULAK 1.026.519 2.612 -- -- -- 3.594 -- -- -- --
TÜYAR -- 57.374 -- -- -- -- -- -- -- --
EHSİM -- 176.629 -- -- 2.901 53.406 -- -- -- --
13.916.652 2.104.707 -- 44.179.971 1.460.466 2.706.034 6.678.940 374.607 -- 7.709.024

1 All other short term payable is 2023 divident payments.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

4. RELATED PARTY DISCLOSURES (continued)

1 January 1 January
31 March 31 March
2025 2024
Transactions with related parties Purchases Purchases
Main Shareholder
TSKGV 729 601
Main shareholder's subsidiaries and associates
NETAŞ 49.679 39.072
STM 20.234 3.979
İŞBİR 140.561 60.200
HTR 317.773 237.367
TUSAŞ 768 315
HAVELSAN 73.665 11.742
Financial Instruments
ASPİLSAN 36.221 50.214
Joint ventures and its related parties
İHSAN DOĞRAMACI BİLKENT ÜNİVERSİTESİ 12.150 717
TÜBİTAK BİLGEM 16.756 100.599
TÜBİTAK BİLİMSEL TEKNOLOJİK ARAŞTIRMA 6.950 3.328
TÜBİTAK UME -- 660
TÜBİTAK SAGE SAVUNMA SANAYİİ 103.930 157.657
779.416 666.451

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

4. RELATED PARTY DISCLOSURES (continued)

1 January 1 January
31 March 31 March
2025 2024
Transactions with related parties Sales Sales
Main Shareholder
TSKGV 171 60
Main shareholder's subsidiaries and associates
TUSAŞ 3.701.351 4.355.963
STM 153.044 1.904.853
HAVELSAN 53.525 13.721
HTR 7.028 14.102
NETAŞ 5 --
Financial Instruments
ROKETSAN 1.083.894 778.226
ASPİLSAN 1 145
Joint ventures and its related parties
TÜBİTAK BİLİMSEL TEKNOLOJİK ARAŞTIRMA 9.986 40.227
TÜBİTAK SAGE SAVUNMA SANAYİİ 3.721 53.725
SSB 10.473.121 16.044.809
SSTEK -- 14.660
15.485.847 23.220.491

Transactions with related parties are generally related to the purchases and sales of goods and services related to projects under TFRS 15 "Revenue from Contracts with Customers".

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

5. TRADE RECEIVABLES AND PAYABLES

a) Trade receivables

Details of the Group's trade receivables are as follows:

31 March 31 December
Short-term trade receivables 2025 2024
Trade receivables 13.323.846 17.238.062
Trade receivables from related parties (Note 4) 14.317.623 13.916.652
Notes receivable 30.510 44.774
Other Receivables 9.248 9.353
Doubtful trade receivables 33.413 35.540
Allowance for doubtful trade receivables (-) (33.413) (35.540)
27.681.227 31.208.841
31 March 31 December
Long-term trade receivables 2025 2024
Unbilled receivables from contracts with customers 18.430.180 15.490.905
Trade receivables 847.937 840.592
Unbilled receivables from contracts with customers -
Related party (Note 4) 43.651.185 44.179.971
62.929.302 60.511.468

The movement for the Group's allowance for doubtful receivables is as follows:

31 March 31 March
2025 2024
Opening balance 35.540 84.185
Provision for the period 1.122 2.917
Monetary gain/(loss) (3.249) (11.021)
Closing balance 33.413 76.081

b) Trade payables

Details of The Group's trade payables are as follows:

31 March 31 December
Short-term trade payables 2025 2024
Trade payables 11.846.555 17.349.918
Due to related parties (Note 4) 1.480.399 2.706.034
Notes Payable 63.020 1.237.817
Other trade payables 345.142 455.267
13.735.116 21.749.036

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

6. INVENTORIES

31 March 31 December
2025 2024
Raw materials 28.403.771 28.198.167
Work-in progress 14.032.857 13.814.594
Goods in transit 1 1.573 23.026
Finished goods 2.048.529 1.705.781
Other inventories 629.482 3.018.534
Trade goods 1.451.175 1.109.219
Allowance for impairment on inventories (-) (66.276) (23.026)
46.501.111 47.846.295

The Group provides an allowance for impairment on inventories when the inventories net realizable values are lower than their costs or when they are determined as slow-moving inventories.

The Group has identified raw material, work-in progress and finished goods inventories below net realizable value within the current year.

Impaired inventory movements for the period ended in 31 March are as follows:

2025 2024
Opening balance 23.026 121.481
Provision for the period 174.265 38.939
Provision unrealised (131.015) (61.801)
Closing balance 66.276 98.619

1 Goods in transit includes the goods for which significant risks and rewards of ownership has been transferred to the Group due to their shipping terms.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

7. PREPAID EXPENSES AND DEFERRED INCOME

31 March 31 December
Short-term prepaid expenses 2025 2024
Order advances given for inventory purchases 11.768.527 8.653.572
Short-term order advances given to related
parties for inventory purchases (Note 4) 2.514.291 2.104.707
Work advances 1.005.382 779.918
Prepaid expenses 2.158.485 1.902.762
17.446.685 13.440.959
31 March 31 December
Long-term prepaid expenses 2025 2024
Long-term order advances given to related
parties for inventory purchases (Note 4) 1.282.346 1.460.466
Order advances given for inventory purchases 1.535.433 1.477.026
Order advances given for fixed assets purchases 373.225 523.497
Prepaid expenses 637.245 653.925
3.828.249 4.114.914
31 March 31 December
Short-term deferred income 2025 2024
Order advances received 3.679.367 4.065.588
Order advances received from related parties
(Note 4) 5.516.184 6.678.940
Deffered income 6.118.960 3.568.659
15.314.511 14.313.187
31 March 31 December
Long-term deferred income 2025 2024
Order advances received 9.207.282 4.880.034
Order advances received from related parties
(Note 4) 16.036.808 7.709.024
Deferred income 2.279.241 429.745
27.523.331 13.018.803

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

8. PROPERTY, PLANT AND EQUIPMENT

Cost Property, Plant
and Equipment
Intangible
Assets
Opening balance as of 1 January 2025 68.939.373 37.331.230
Additions 1.562.120 4.406.919
Disposals (244.034) (1.950.295)
Closing balance as of 31 March 2025 70.257.459 39.787.854
Accumulated Depreciation and Amortisation
Opening balance as of 1 January 2025 27.765.859 13.302.959
Change for the period1 991.545 307.720
Disposals (27.578) (194.764)
Closing balance as of 31 March 2025 28.729.826 13.415.915
Net book value as of 31 March 2025 41.527.633 26.371.939
Net book value as of 31 December 2024 41.173.514 24.028.271
Property, Plant Intangible
Assets
64.069.777 27.394.232
940.770 2.696.440
(760.734) (885.947)
-- --
29.204.725
26.361.371 8.090.533
778.622 277.408
(470.555) (140.097)
26.669.438 8.227.844
37.580.375 20.976.881
37.708.406 19.303.699
and Equipment
64.249.813

In accordance with TFRS 13 "Fair Value Measurement" standard, fair values of the lands are considered as level three of fair value hierarchy, since measurement techniques do not include observable market inputs.

1 The amount of amortization related to inventories are TL 128.103 in the year 2025 (March 2024: TL 103.391)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

9. PROVISIONS, CONTINGENT ASSETS AND LIABILITIES

a) Provisions

31 March 31 December
Other short-term provisions 2025 2024
Provision for warranties1 3.643.381 4.337.480
Provision for onerous contracts 218.200 240.158
Provision for delay penalties2 2.817.133 2.108.334
Sales commission 114.715 126.259
Provision for legal cases 56.752 60.111
Provision for cost expenses 286.103 712.071
Other 76.229 23.917
7.212.513 7.608.330
31 March 31 December
Other long-term provisions 2025 2024
Provision for delay penalties 503.017 553.636
Provision for onerous contracts 8.600.722 9.364.011
9.103.739 9.917.647

b) Legal cases

There has not been any final judicial decision against the Group due to the responsibility related with work accidents within 2025.

As of the dates 31 March 2025 and 31 December 2024, according to the declarations written by the legal counselors, the lawsuits and legal executions in favor of and against the Group are as follows:

Description 202 5 2024
a) Ongoing lawsuits filed by the Group 26.481 47.179
b) Execution proceedings carried out by the Group 730.428 822.057
c) Ongoing lawsuits filed against the Group 56.752 60.112
d) Executions against the Group 16.637 21.098
e) Lawsuits finalized against the Group within the period 1.531 7.769
f) Lawsuits finalized in favor of the Group within the
period 20.468 5.453

a) Ongoing lawsuits filed by the Group are comprised of lawsuits for patents, trademarks and lawsuits filed by the Group due to the disagreements related to previous lawsuits. These lawsuits will not be recognised in the financial statements until they are finalized.

b) Execution of proceedings carried out by the Group are comprised of lawsuits that would result in favor of the Group that will be recognised as revenue under "Other Operating Income" line when they are collected.

c) The Company made provisions for all lawsuits filed against the Group and recognised as "Provisions" in the statement of financial positon and "Other Operating Expense" in the statement of profit or loss and other comprehensive income.

d) Executions against the Group are not included in Financial Statements.

e) Lawsuits finalized against the Group are recognised in the statement of profit or loss to the extent that the amount differs from the amount previously provided. Amounts in excess of the amount previously provided are recognised under 'Other Operating Expense' when the penalty is paid.

f) Lawsuits finalized in favor of the Group are recognised in statement of profit or loss and other comprehensive income under "Other Operating Income" line when the final judgement is determined.

1 The Group's provision for warranty is based on sales under warranty are estimated in accordance with historical data. Provision for warranty is calculated by using warranty rate included in the contract as long as the invoice issued throughout the life of the Contract

2 Provision for delay penalties and fines are calculated in accordance with interest rates mentioned in the agreement for defaulet and within the client's knowledge.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

10. TAX

"Deferred Tax Assets" of the Group as of 31 March 2025 is TL 12.504.809. The amount is comprised of the items below.

31 March 31 December
2025 2024
Carried Forward R&D Incentives Effect 14.194.198 9.651.464
Temporary Differences (1.689.389) (683.435)
Deferred Tax Assets - Net 12.504.809 8.968.029

The earnings gained within the scope of Technology Development Zones Law numbered 4691 and the Support of Research and Development Activities Law numbered 5746 were exempted from corporate tax until 31 December 2028.

Forecasts, expected duration of research and development incentives and temporary differences are considered in calculating deferred tax asset.

In accordance with the law numbered 5746 pertaining to 1 January-31 March 2025 period the Group has calculated "Deferred Tax Asset" amounting to TL 14.194.198 from Research and Development expenses comprising "Outstanding Research and Development Deductions".

31 March 31 March
2025 2024
Profit before tax from continuing operations (2.135.531) (736.481)
Tax (expense)/income recognized in profit or loss 4.269.022 2.447.474
Effective tax rate (%200) (%332)

Effective tax rate is calculated by dividing net tax income recognized in profit or loss to profit before tax from continuing operations.

11. COMMITMENTS AND CONTINGENCIES

a) Guarantees received

31 March 2025 31 December 2024
Letters of guarantees received from the suppliers 10.718.537 10.759.871
Collaterals received from the customers 749.499 744.706
Letters of guarantees received from the customers -- 49.207
Collaterals received from the suppliers 1.556.684 1.525.608
Letters of guarantees received from the suppliers 485.925 518.383
Letters of guarantees received from the customers -- 2.201
13.510.645 13.599.976

b) Collaterals / Pledges / Mortgages ("CPM") given

The collaterals/pledges/mortgages ("CPM") given by the Group as of 31 March 2025 and 31 December 2024 is as follows:

In accordance with the terms of the Patrol and Anti-Submarine Warfare Ship Projects ("MİLGEM"), the Company is a guarantor if HAVELSAN cannot be able to fulfill the obligations in this project of an amount of USD 294.403.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

11. COMMITMENTS AND CONTINGENCIES (continued)

c) Guarantees given

31 March 2025 TL Equivalent TL USD EURO Rumen Leyi Qatar Rial
A. Total amount of CPM given on behalf of the legal
entity
-Collateral 18.152.811 2.660.883 276.830 122.897 4.004 250
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
B. Total amount of CPM given on behalf of the
subsidiaries included in full consolidation
-Collateral 162.808 -- -- 4.000 -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
C. Total amount of CPM given to maintain operations
and collect payables from third parties
-Collateral -- -- -- -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
D. Total amount of other CPM given
i. Total Amount of CPM on behalf of the main partner
-Collateral -- -- -- -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
ii. Total amount of CPM given on behalf of other
1
group companies that do not cover B and C
-Collateral 16.957 -- 449 -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
iii. Total amount of CPM on behalf of third parties
that do not cover
-Collateral -- -- -- -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
Total 18.332.576 2.660.883 277.279 126.897 4.004 250

1 The ratio of the other CPM given by the Group to equity as of 31 March 2025 is 0,01 percent. TL 16.957 is the collateral amount pertaing to guarantee letter given on behalf of the entity's joint venture ASELSAN Bilkent.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

11. COMMITMENTS AND CONTINGENCIES (continued)

c) Guarantees given (continued)

31 December 2024 TL Equivalent TL USD EURO Rumen Leyi Qatar Rial
A. Total amount of CPM given on behalf of the legal
entity
-Collateral 17.249.015 2.376.455 278.011 100.387 4.004 250
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
B. Total amount of CPM given on behalf of the
subsidiaries included in full consolidation
-Collateral 161.762 -- -- 4.000 -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
C. Total amount of CPM given to maintain operations
and collect payables from third parties
-Collateral -- -- -- -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
D. Total amount of other CPM given
i. Total Amount of CPM on behalf of the main partner
-Collateral -- -- -- -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
ii. Total amount of CPM given on behalf of other
group companies that do not cover B and C
1
-Collateral 49.235 -- 1.270 -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
iii. Total amount of CPM on behalf of third parties
that do not cover
-Collateral -- -- -- -- -- --
-Pledge -- -- -- -- -- --
-Mortgage -- -- -- -- -- --
Total 17.460.012 2.376.455 279.281 104.387 4.004 250

1 The ratio of the other CPM given by the Group to equity as of 31 December 2024 is 0,03 percent. TL 49.236 is the collateral amount pertaing to guarantee letter given on behalf of the entity's joint venture ASELSAN Bilkent.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

12. EMPLOYEE BENEFITS

a) Short-term provisions for employee benefits

31 March 2025 31 December 2024
Provision for vacation pay and overtime 1.513.519 1.248.198
Bonus provision -- 2.117.435
1.513.519 3.365.633

As of 31 March the movement of the provision for vacation pay and overtime is as follows:

2025 2024
Opening balance 1.248.198 1.114.971
Provision for the period 461.702 140.575
Provision paid during the period (77.339) (67.354)
Provision realized during the period (4.921) (6.806)
Monetary gain/(loss) (114.121) (129.708)
Closing balance 1.513.519 1.051.678

b) Long-term provisions for employee benefits

31 March 2025 31 December 2024
Provision for severance pay 1.082.518 1.157.157
1.082.518 1.157.157

As of 31 March the movement of severance and retirement pays are as follows:

2025 2024
Opening balance 1.157.157 1.689.627
Service cost 402.374 111.618
Payments (371.215) (77.103)
Monetary gain/(loss) (105.798) (221.199)
Closing balance 1.082.518 1.502.943

Provision for severance pay:

In accordance with the Labor Law Legislations, the Group is obliged to make legal severance indemnity payments to entitled employees whose employment has been terminated. Furthermore, with regard to Social Security Law numbered 506 dated 6 March 1981, number 2422 dated 25 August 1999 and law numbered 4447, article 60 denotes the legal obligation to make severance payments to all employees who are entitled to indemnity by the date of leave of employment.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

12. EMPLOYEE BENEFITS (continued)

Provision for severance pay (continued)

Certain provisions regarding services before retirement, has been annulled on 23 May 2002 during the revision of the related law. As of 31 March 2025 severance payments are calculated on the basis of 30 days' pay, limited to a ceiling of TL 46.655,43 (31 December 2024: TL 46.655,43)

The liability is not funded, as there is no funding requirement. The provision has been calculated by estimating the present value of the future probable obligation of the Group arising from the retirement of employees. TAS 19 ("Employee Benefits") requires actuarial valuation methods to be developed to estimate the entity's obligation under defined benefit plans.

Accordingly, the following actuarial assumptions were used in the calculation of the total liability:

31 March 2025
(%)
31 December 2024
(%)
Interest rate 24,90 24,90
Inflation rate 21,05 21,05
Discount ratio 3,18 3,18
Estimation of probability of retirement ratio 94 94

13. SHARE CAPITAL, RESERVES AND OTHER EQUITY ITEMS

Capital
---------
Shareholders Share (%) 31 March 2025 Share (%) 31 December 2024
TSKGV 74,20 3.383.302 74,20 3.383.302
Publicly held 25,80 1.176.698 25,80 1.176.698
Nominal capital 100 4.560.000 100 4.560.000
Share capital adjustment 27.093.175 27.093.175
Inflation adjusted capital 31.653.175 31.653.175

The Group's nominal capital is TL 4.560.000 comprising 4.560.000.000 shares each of which is TL 1. A total of 2.421.818.182 of the shares constitutes "Group A" and 2.138.181.818 of the shares constitutes "Group B" shares. All of the shares are nominative. "Group A" shares are privileged nominative shares and 6 Members of the Board of Directors are assigned from the holders of nominative "Group A" type shareholders or from the ones nominated by "Group A" type shareholders. Moreover, the Board of Directors shall be authorized in matters regarding issuing preferred shares or issuing shares above the nominal values. Regarding capital increases by restricting preemptive rights, the shares to be issued shall be "Group B". In accordance with the CMB's legislation, other Members of the Board of Directors, not including elected Independent Members of the Board of Directors, are assigned from nominative "Group A" shareholders or elected from among candidate nominated by "Group A" shareholders.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

13. SHARE CAPITAL, RESERVES AND OTHER EQUITY ITEMS (continued)

Restricted reserves

In accordance with Capital Markets Board's Communique Serial II No:19.1 "Share of Profit", effective as of 1 February 2014, and with regard to the Turkish Commercial Code ("TCC"), legal reserves in publicly held companies will be generated by 5 percent of income until it reaches 20 percent of paid-in share capital. After the 5 percent of the dividend is paid to shareholders, 10 percent of the total distributed to shareholders and employees can be added in the other legal reserve. Under the TCC, the legal reserves can be used only to offset losses for the going concern of the company or to prevent unemployment as long as the amount does not exceed 50 percent of the paid-in capital.

Retained Earnings

Accumulated profits apart from net profit for the year and extraordinary reserves which is accumulated profit by nature are shown under retained earnings.

Profit distribution

Publicly traded companies perform dividend distribution in accordance with Capital Markets Board's Communique Serial II No: 19.1 "Share of Profit", effective as of 1 February 2014.

Shareholders, distribute dividend with general assembly decision, within the context of profit distribution policies set by general assembly and related regulations. As part of the communique, no specific minimum distribution ratio is indicated. Companies pay dividend as defined in their articles of association or dividend distribution policies.

14. REVENUE AND COST OF SALES

1 January- 1 January
31 March 31 March
a) Revenue 2025 2024
Domestic sales 19.969.614 17.062.385
Export sales 2.821.159 3.845.226
22.790.773 20.907.611
1 January - 1 January -
31 March 31 March
Revenue Recognized Regarding Performance Obligation 2025 2024
Over time 17.561.384 17.387.336
Point in time 5.229.389 3.520.275
22.790.773 20.907.611
b) Cost of sales(-) 1 January-
31 March
2025
1 January
31 March
2024
Cost of raw materials and supplies (-) 11.319.103 11.205.610
Cost of merchandise goods sold (-) 284.159 1.819.212
Cost of services sold (-) 4.150.195 1.382.125
Cost of other sales (-) 215.943 450.821
15.969.400 14.857.768

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

15. OTHER OPERATING INCOME AND EXPENSES

a) Other operating income 1 January- 1 January
31 March 31 March
2025 2024
Foreign currency exchange differences from operations 9.086.994 6.435.486
Amortized cost effect of trade payables 817.931 1.180.302
Other income 323.938 377.191
10.228.863 7.992.979
b)
Other operating expense (-)
1 January- 1 January
31 March 31 March
2025 2024
Foreign currency exchange differences from operations (-) 5.871.366 4.360.884
Amortized cost effect of trade receivables (-) 630.042 592.217
Other expense and losses (-) 292.236 589.638
6.793.644 5.542.739

1 January-
31 March
1 January
31 March
2025 2024
Interest income 813.418 263.353
Foreign currency exchange gains from bank loans 31.335 108.516
844.753 371.869

17. FINANCIAL EXPENSES

1 January
31 March
1 January
31 March
2025 2024
Foreign currency exchange losses from bank loans (-)
Interest cost of borrowings (-)
2.732.555 1.549.405
561.832 969.183
3.294.387 2.518.588

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

18. GAIN/(LOSS) ON NET MONETARY POSITION

As of 31 March 2025, the details of the net monetary position gains (losses) arising from non-monetary financial statement items reported in the Group's profit or loss statement are as follows:

Net Monetary Gain/ (Losses) 31 March 2025
Balance Sheet Items (6.844.866)
Inventories 138.269
Prepaid expenses 1.522.712
Property, plant and equipment 3.082.508
Intangible assets 2.451.647
Equity accounted investments and financial investments 1.211.649
Deferred income (1.121.162)
Share capital (2.894.033)
Share premiums (2.113.709)
Other comprehensive income / (expense) that will not be reclassified
to profit or (loss) (336.167)
Other comprehensive income / (expense) that will be reclassified to
profit or (loss) 49.298
Restricted reserves (501.426)
Retained earnings (8.334.452)
Statement of Profit or Loss Items (181.006)
Revenue (527.657)
Cost of sales (-) 306.576
General administrative expenses (-) 21.527
Marketing expenses (-) 12.151
Research and development expenses (-) 11.505
Other operating ıncome (228.601)
Other operating expenses (-) 199.325
Income from investing activities (389)
Financial income (20.002)
Financial expense (-) 44.559
Net Monetary Gain/ (Losses) (7.025.872)

19. EARNINGS PER SHARE

Earnings per share is calculated by dividing profit or loss attributable to ordinary equity holders of the parent entity by the weighted average number of ordinary shares outstanding during the period. The Group does not have diluted shares.

For the 31 March 2025 and 2024 earnings per share calculations are as follows:

1 January- 1 January
31 March 31 March
2025 2024
Number of shares outstanding (in thousands) 4.560.000 2.280.000
Net profit – TL 2.274.816 1.938.650
Earnings per 100 shares (kuruş) 49,89 42,51
Diluted earnings per 100 shares (kuruş) 49,89 42,51

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

20. FINANCIAL LIABILITIES

Financial Liabilities

31 March 31 December
2025 2024
Short-term financial liabilities Unsecured loan 5.957.478 14.863.146
Other short-term financial liabilities Unsecured loan 79.351 66.645
Current portion of long-term financial
liabilities Unsecured loan 26.736.849 10.203.729
Total short-term financial liabilities 32.773.678 25.133.520
Other long-term financial liabilities Unsecured loan 171.730 10.705.550
Total long-term financial liabilities 171.730 10.705.550
Total financial liabilities 32.945.408 35.839.070

As of 31 March 2025, TL 5.272.445 of the financial debts included in short-term borrowings consists of EUR Rediscount Foreign Currency Loans, which have maturity dates due between May 2025 and December 2025 and the interest rates between 3,15 percent and 4,50 percent. As of 31 March 2025, TL 377.656 of financial debts within short-term borrowings consist of USD Rediscount Foreign Currency Loans, which have maturity dates due August 2025 and the interest rate is 5,99 percent. As of 31 March 2025, TL 307.377 of financial debts within short-term borrowings consist of TL Rediscount Foreign Currency Loans, which have maturity dates due April 2025 and the interest rates is 26,93 percent.

As of 31 March 2025, there are TL 14.274.201 Spot EUR Loans within the short-term borrowings, which have maturity dates due between July 2025 and February 2025, and the interest rates between 4,50 percent and 5,10 percent. As of 31 March 2025, there are TL 12.462.648 Spot USD Loans within the short-term borrowings, which have maturity dates due between July 2025 and March 2026, and the interest rates between 5,25 percent and 5,99 percent.

As of 31 March 2025, TL 79.351 of other short-term financial liabilities were taken within the scope of investment credit, which have maturity dates due November 2025, and the interest rates 49,00 percent.

As of 31 March 2025, TL 171.730 of financial debts included in the long-term borrowings were taken within the scope of investment credit, which have maturity dates due October 2027 and the interest rate is between 8,25 percent and 12,50 percent.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

20. FINANCIAL LIABILITIES (continued)

Financial Liabilities (continued)

As of 31 December 2024, TL 3.639.630 of the financial debts included in short-term borrowings consists of EUR Rediscount Foreign Currency Loans, which have maturity dates due between May 2025 and December 2025 and the interest rates between 4,29 percent and 4,42 percent. As of 31 December 2024, TL 5.459.446 of the financial debts included in short-term borrowings consists of EUR Spot Loans, which have maturity dates due between January 2025 and November 2025 and the interest rates between 4,30 percent and 5,95 percent. As of 31 December 2024, TL 5.326.161 of financial debts within short-term borrowings consist of USD Spot Loans, which have maturity dates due between February 2025 and August 2025 and the interest rate is between 5,70 percent and 6,75 percent. As of 31 December 2024, TL 38.522 of financial debts within short-term borrowings consist of TL Rediscount Foreign Currency Loans, which have maturity dates due between April 2025 and the interest rates 26,93 percent. As of 31 December 2024, TL 399.387 of financial debts within short-term borrowings consist of TL investment loans, which have maturity dates due between November 2025 and the interest rates 49 percent.

As of 31 December 2024, there are TL 7.279.261 EUR Spot Loans within the short-term borrowings, which have maturity dates due between July 2025 and October 2025, and the interest rates between 4,99 percent and 5,00 percent. As of 31 December 2024, there are TL 2.924.468 USD Spot Loans within the short-term borrowings, which have maturity dates due between February 2025 and August 2025, and the interest rates between 5,25 percent and 5,99 percent.

As of 31 December 2024, TL 66.645 of other short-term financial liabilities were taken within the scope of investment credit, which have maturity dates due November 2025, and the interest rates 49 percent.

As of 31 December 2024, TL 4.529.318 of the financial debts included in the long-term borrowings consists of EUR Spot Loans, which have maturity dates due February 2026 and the interest rates between 4,75 and 5,10 percent. As of 31 December 2024, TL 5.971.349 of the financial debts included in the long-term borrowings consists of USD Spot Loans, which have maturity dates due January 2026 and the interest rates 5,85 percent.

As of 31 December 2024, TL 204.883 of financial debts included in the long-term borrowings were taken within the scope of investment credit, which have maturity dates due December 2026 and the interest rate is between 9 percent and 17,50 percent.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

21. FOREIGN EXCHANGE POSITION

FOREIGN EXCHANGE POSITION
TL Equivalent TL equivalent by TL equivalent by
(Functional USD using closing EURO using closing Other1
31
March
2025
currency) rates rates
1. Trade receivables 15.583.993 327.632 12.373.222 78.885 3.210.771 --
2a. Monetary financial assets (including cash,
bank) 2.134.035 29.518 1.114.758 24.963 1.016.054 3.223
2b. Non-
monetary financial assets
10.827.946 125.056 4.722.817 61.793 2.515.083 155.234
3. Other 52.476 1.268 47.882 105 4.264 330
4. Current assets (1+2+3) 28.598.450 483.474 18.258.679 165.746 6.746.172 158.787
5. Trade receivables 49.058.976 557.612 21.058.561 687.939 28.000.415 --
6a. Monetary trade receivables -- -- -- -- -- --
6b. Non-monetary trade receivables 442.247 804 30.356 2.256 91.826 15.151
7. Other 84.247 974 36.790 847 34.478 12.979
8. Long-term assets (5+6+7) 49.585.470 559.390 21.125.707 691.042 28.126.719 28.130
9. Total assets (4+8) 78.183.920 1.042.864 39.384.386 856.788 34.872.891 186.917
10. Trade payables 5.361.737 99.828 3.776.850 33.123 1.350.609 234.278
11. Financial liabilities 32.122.011 340.333 12.876.069 472.000 19.245.942 --
12a. Other monetary financial liabilities 18.112 423 16.009 52 2.103 --
12b. Other non-monetary financial liabilities 8.861.634 259.903 9.833.083 99.452 4.055.189 --
13. Current liabilities (10+11+12) 46.363.494 700.487 26.502.011 604.627 24.653.843 234.278
14. Trade payables -- -- -- -- -- --
15. Financial liabilities 100.890 2.667 100.890 -- -- --
16a. Other monetary financial liabilities 7.579 132 4.989 64 2.590 --
16b. Other non-monetary financial liabilities 18.237.039 368.023 13.898.594 156.891 6.397.277 --
17. Non-current liabilities (14+15+16) 18.345.508 370.822 14.004.473 156.955 6.399.867 --

1 Comprises of the currencies CAD, CHF, GBP, JPY, AUD, DKK, ZAR, AED, PHP, SAR.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

21. FOREIGN EXCHANGE POSITION (continued)

FOREIGN EXCHANGE POSITION
TL Equivalent TL equivalent by TL equivalent by
(Functional USD using closing EURO using closing Other
31 March 2025 currency) rates rates
18. Total liabilities (13+17) 64.709.002 1.071.309 40.506.484 761.582 31.053.710 234.278
19. Net asset/liability position of off
balance sheet derivative financial
instruments (19a-19b) -- -- -- -- -- --
19a. Hedged total financial assets -- -- -- -- -- --
19b. Hedged total financial liabilities -- -- -- -- -- --
20. Net foreign currency asset/liability (9-
18+19) 13.474.918 (28.445) (1.122.098) 95.206 3.819.181 (47.361)
21. Net foreign currency asset / liability
position of monetary items (1+2a+5+6a-10-
11-12a-14-15-16a) 29.166.675 471.379 17.771.734 286.548 11.625.996 (231.055)
22. Fair value of derivative financial
instruments used in foreign currency hedge -- -- -- -- -- --
23. Hedged foreign currency assets -- -- -- -- -- --
24. Hedged foreign currency liabilities -- -- -- -- -- --
25. Exports 2.821.159 52.982 1.910.845 7.532 284.251 626.063
26. Imports 9.658.811 167.657 6.343.103 55.401 2.258.990 1.056.718

Accompanying foreign exchange position which was prepared in accordance with TAS is different from the foreign exchange position of the financial statement which is prepared according to General Communiqué on Accounting System Application (GCASA). The difference is mainly due to the adjustments and classifications which are related with TFRS 15 .

"For TL functional currency" calculations regarding "Other non-monetary assets" and "Other non-monetary liabilities" presented under foreign currency position, advances received are considered with regard to historic values therefore "TL equivalent of currency as at balance sheet date" differentiate.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

21. FOREIGN EXCHANGE POSITION (continued)

FOREIGN EXCHANGE POSITION
TL Equivalent TL equivalent by TL equivalent by
(Functional USD using closing EURO using closing Other1
31 December 2024 currency) rates rates
1. Trade receivables 19.455.190 417.340 16.205.555 80.371 3.249.635 --
2a. Monetary financial assets (including cash,
bank) 2.134.179 40.218 1.561.685 13.668 552.652 19.842
2b. Non-
monetary financial assets
9.354.386 91.482 3.552.289 50.194 2.029.504 109.720
3. Other 14.159 84 3.259 263 10.611 289
4. Current assets (1+2+3) 30.957.914 549.124 21.322.788 144.496 5.842.402 129.851
5. Trade receivables 50.019.606 551.044 21.397.356 707.894 28.622.250 --
6a. Monetary trade receivables -- -- -- -- -- --
6b. Non-monetary trade receivables 426.941 692 26.864 1.951 78.888 15.107
7. Other 240.209 5206 202.157 938 37.942 110
8. Long-term assets (5+6+7) 50.686.756 556.942 21.626.377 710.783 28.739.080 15.217
9. Total assets (4+8) 81.644.670 1.106.066 42.949.165 855.279 34.581.482 145.068
10. Trade payables 9.032.953 168.203 6.543.189 54.030 2.188.529 301.235
11. Financial liabilities 24.334.068 203.833 7.929.208 405.000 16.404.860 --
12a. Other monetary financial liabilities 527.248 13500 525.157 52 2.091 --
12b. Other non-monetary financial liabilities 4.112.791 201.682 7.845.495 28.223 1.143.201 --
13. Current liabilities (10+11+12) 38.007.060 587.218 22.843.049 487.305 19.738.681 301.235
14. Trade payables -- -- -- -- -- --
15. Financial liabilities 10.475.454 152.667 5.938.801 112.000 4.536.653 --
16a. Other monetary financial liabilities 7.702 132 5.130 64 2.572 --
16b. Other non-monetary financial liabilities 5.106.014 191.363 7.444.102 27.991 1.133.812 --
17. Non-current liabilities (14+15+16) 15.589.170 344.162 13.388.033 140.055 5.673.037 --

1 Comprises of the currencies CAD, CHF, GBP, JPY, AUD, DKK, ZAR, AED, PHP, SAR.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

21. FOREIGN EXCHANGE POSITION (continued)

FOREIGN EXCHANGE POSITION
TL Equivalent TL equivalent by
(Functional USD using closing EURO using closing Other
31 December 2024 currency) rates rates
18. Total liabilities (13+17) 53.596.230 931.380 36.231.082 627.360 25.411.718 301.235
19. Net asset/liability position of off
balance sheet derivative financial
instruments (19a-19b) -- -- -- -- -- --
19a. Hedged total financial assets -- -- -- -- -- --
19b. Hedged total financial liabilities -- -- -- -- -- --
20. Net foreign currency asset/liability (9-
18+19) 28.048.440 174.686 6.718.083 227.919 9.169.764 (156.167)
21. Net foreign currency asset /
liability
position of monetary items (1+2a+5+6a-10-
11-12a-14-15-16a) 27.231.550 470.267 18.223.111 230.787 9.289.832 (281.393)
22. Fair value of derivative financial
instruments used in foreign currency hedge -- -- -- -- -- --
23. Hedged foreign currency assets -- -- -- -- -- --
24. Hedged foreign currency liabilities -- -- -- -- -- --
25. Exports 18.871.771 182.178 3.536.850 146.554 3.586.579 11.748.341
26. Imports 22.046.258 378.920 14.690.273 142.582 5.766.045 1.589.940

Accompanying foreign exchange position which was prepared in accordance with TAS is different from the foreign exchange position of the financial statement which is prepared according to General Communiqué on Accounting System Application (GCASA). The difference is mainly due to the adjustments and classifications which are related with TFRS 15.

"For TL functional currency" calculations regarding "Other non-monetary assets" and "Other non-monetary liabilities" presented under foreign currency position, advances received are considered with regard to historic values therefore "TL equivalent of currency as at balance sheet date" differentiate.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

21. FOREIGN EXCHANGE POSITION (continued) Foreign currency sensitivity

The Group is exposed to foreign currency risk with respect to USD and EURO.

The following table details the Group's sensitivity to a 10 percent increase and decrease in foreign exchange rates. 10 percent is the sensitivity rate used when reporting foreign currency risk internally to key management personnel and represents management's assessment of the possible change in foreign exchange rates. The sensitivity analysis includes only outstanding foreign currency denominated monetary items and present 10 percent change in foreign currency rates. This analysis does not include Group companies' balance sheet items which have functional currency other than TL. The effects of 10 percent changes in foreign currency rate on financial statements is as follows;

Foreign currency sensitivity table
31 March 2025
Profit/Loss Equity1
Appreciation Depreciation Appreciation Depreciation
of foreign of foreign of foreign of foreign
currency currency currency currency
Change of USD against TL by 10%:
1- USD denominated net
assets/(liabilities) 1.777.173 (1.777.173) 1.777.173 (1.777.173)
2- Hedged amount against
USD risk (-) -- -- -- --
3- Net effect of USD (1+2) 1.777.173 (1.777.173) 1.777.173 (1.777.173)
Change of EURO against TL by 10%:
4- EURO denominated net
assets/(liabilities) 1.162.600 (1.162.600) 1.162.600 (1.162.600)
5- Hedged amount against
EURO risk (-) -- -- -- --
6- Net effect of EURO (4+5) 1.162.600 (1.162.600) 1.162.600 (1.162.600)
Change of other currencies against TL by 10%:
7- Other currencies
denominated net assets/
(liabilities) (23.105) 23.105 (23.105) 23.105
8- Hedged amount against
other currencies risk (-) -- -- -- --
9- Net effect of other
currencies (7+8) (23.105) 23.105 (23.105) 23.105

1 Comprises of profit/loss effect.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

21. FOREIGN EXCHANGE POSITION (continued)

Foreign currency sensitivity (continued)

Foreign currency sensitivity table
31 December 2024
Profit/Loss Equity1
Appreciation
Depreciation
Appreciation Depreciation
of foreign of foreign of foreign of foreign
currency currency currency currency
Change of USD against TL by 10%:
1- USD denominated net
assets/(liabilities) 1.822.311 (1.822.311) 1.822.311 (1.822.311)
2- Hedged amount against USD risk (-) -- -- -- --
3- Net effect of USD (1+2) 1.822.311 (1.822.311) 1.822.311 (1.822.311)
Change of EURO against TL by 10%:
4- EURO denominated net
assets/(liabilities) 928.983 (928.983) 928.983 (928.983)
5- Hedged amount against EURO risk (-) -- -- -- --
6- Net effect of EURO (4+5) 928.983 (928.983) 928.983 (928.983)
Change of other currencies against TL by 10%:
7- Other currencies denominated net
assets/ (liabilities) (28.139) 28.139 (28.139) 28.139
8- Hedged amount against other
currencies risk (-) -- -- -- --
9- Net effect of other currencies (7+8)
(28.139)
28.139
(28.139)
28.139

1 Comprises of profit/loss effect.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTH ENDED 31 MARCH 2025

(Amounts are expressed in Thousand Turkish Lira ("TL") in terms of the purchasing power of the TL at 31 March 2025, unless otherwise indicated.)

22. EVENTS AFTER THE REPORTING PERIOD

After the reporting period, the Group have signed contracts amounting to USD 202 Million.

As per the resolution of our Board of Directors dated 25 March 2025, Dr. Nurettin TÜYSÜZ has been appointed as the Chief Financial Officer of our Company, effective as of 2 April 2025.

Talk to a Data Expert

Have a question? We'll get back to you promptly.